Cubist Systematic Strategies’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Cubist Systematic Strategies’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43,027	Closed	-$12.8K	–	4213
2023 Q2	$12.8K	Buy	+43,027	New	+$13K	﹤0.01%	3233

Cubist Systematic Strategies's GRNA Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 43,027 shares — an estimated $12.8K sold.

Cubist Systematic Strategies first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $12.8K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Cubist Systematic Strategies reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 43,027 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $12.8K.
Cubist Systematic Strategies first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
Cubist Systematic Strategies's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $12.8K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.